The second part of the Global Pharma.3 Executive Course began on May 16th and featured guest speaker Filipa Mota e Costa, Managing Director at J&J Innovative Medicine Portugal. This session focused on the topic ‘Trends and the Future of Healthcare‘.
After the first part of the course took place at the facilities of Católica Medical School, the second part is now being held at Hospital da Luz Learning Health.
André de Aragão Azevedo, Member of the ESNA Advisory Board; Paulo Barradas Rebelo, President at Bluepharma; Sofia Ferreira, Managing Director at Organon Portugal; André Correia, Executive VP at SERaro.pt and Sérgio Alves, Operations Director Portugal at Ascendi Pharma are some of the other distinguished guests who will be sharing their professional experience in the pharmaceutical industry.
We hope this second part of the executive course will be as enriching as the first!
🔗 More information about this executive course: https://www.thegenh.com/gp3
